Published Date: 08 Mar 2023
Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.
Read Full News1.
Dense breasts: What it means and what women can do about screening
2.
New target points to combination therapy for thwarting multidrug resistance in cancer treatment
3.
Potential targets for treating the most common type of liver cancer in children have been identified by a collaborative study.
4.
Discovery of a new biomarker for early detection of bladder cancer in both dogs and humans
5.
The Higher the Disability Burden From Disease, the Higher the Suicide Risk
1.
Toripalimab + Nab-Paclitaxel in PD-L1+ TNBC: Phase 3 TORCHLIGHT Trial Results
2.
Understanding the Causes and Symptoms of Cavernous Sinus Thrombosis
3.
Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options
4.
The Basics of M.C.V Normal Range for Better Health Management
5.
Checkpoint Inhibitors in Oncology: Advances in PD-1/PD-L1 and CTLA-4 Targeted Therapy
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
Current Scenario of Cancer- The Incidence of Cancer in Men
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
4.
Thromboprophylaxis In Medical Settings
5.
Navigating the Complexities of Ph Negative ALL - Part XV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation